UniProt ID | SNIP1_HUMAN | |
---|---|---|
UniProt AC | Q8TAD8 | |
Protein Name | Smad nuclear-interacting protein 1 | |
Gene Name | SNIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 396 | |
Subcellular Localization | Nucleus . | |
Protein Description | Down-regulates NF-kappa-B signaling by competing with RELA for CREBBP/EP300 binding. Involved in the microRNA (miRNA) biogenesis. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA.. | |
Protein Sequence | MKAVKSERERGSRRRHRDGDVVLPAGVVVKQERLSPEVAPPAHRRPDHSGGSPSPPTSEPARSGHRGNRARGVSRSPPKKKNKASGRRSKSPRSKRNRSPHHSTVKVKQEREDHPRRGREDRQHREPSEQEHRRARNSDRDRHRGHSHQRRTSNERPGSGQGQGRDRDTQNLQAQEEEREFYNARRREHRQRNDVGGGGSESQELVPRPGGNNKEKEVPAKEKPSFELSGALLEDTNTFRGVVIKYSEPPEARIPKKRWRLYPFKNDEVLPVMYIHRQSAYLLGRHRRIADIPIDHPSCSKQHAVFQYRLVEYTRADGTVGRRVKPYIIDLGSGNGTFLNNKRIEPQRYYELKEKDVLKFGFSSREYVLLHESSDTSEIDRKDDEDEEEEEEVSDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MKAVKSERE ------CCCCCCCHH | 62.98 | 25953088 | |
5 | Sumoylation | ---MKAVKSERERGS ---CCCCCCCHHHCC | 52.00 | - | |
5 | Acetylation | ---MKAVKSERERGS ---CCCCCCCHHHCC | 52.00 | 25953088 | |
6 | Phosphorylation | --MKAVKSERERGSR --CCCCCCCHHHCCC | 34.97 | 26437602 | |
12 | Phosphorylation | KSERERGSRRRHRDG CCCHHHCCCCCCCCC | 28.92 | - | |
30 | Sumoylation | LPAGVVVKQERLSPE ECCEEEEEECCCCCC | 34.53 | - | |
30 | Sumoylation | LPAGVVVKQERLSPE ECCEEEEEECCCCCC | 34.53 | 25114211 | |
30 | Acetylation | LPAGVVVKQERLSPE ECCEEEEEECCCCCC | 34.53 | 25953088 | |
35 | Phosphorylation | VVKQERLSPEVAPPA EEEECCCCCCCCCCC | 25.82 | 29255136 | |
49 | Phosphorylation | AHRRPDHSGGSPSPP CCCCCCCCCCCCCCC | 52.83 | 29255136 | |
52 | Phosphorylation | RPDHSGGSPSPPTSE CCCCCCCCCCCCCCC | 26.23 | 29255136 | |
54 | Phosphorylation | DHSGGSPSPPTSEPA CCCCCCCCCCCCCCC | 45.25 | 29255136 | |
57 | Phosphorylation | GGSPSPPTSEPARSG CCCCCCCCCCCCCCC | 49.45 | 30266825 | |
58 | Phosphorylation | GSPSPPTSEPARSGH CCCCCCCCCCCCCCC | 47.56 | 29255136 | |
63 | Phosphorylation | PTSEPARSGHRGNRA CCCCCCCCCCCCCCC | 40.85 | 28111955 | |
74 | Phosphorylation | GNRARGVSRSPPKKK CCCCCCCCCCCCCCC | 29.84 | 23401153 | |
76 | Phosphorylation | RARGVSRSPPKKKNK CCCCCCCCCCCCCCC | 37.74 | 23401153 | |
79 | Acetylation | GVSRSPPKKKNKASG CCCCCCCCCCCCCCC | 78.68 | 12432625 | |
80 | Acetylation | VSRSPPKKKNKASGR CCCCCCCCCCCCCCC | 68.31 | 12432635 | |
89 | Phosphorylation | NKASGRRSKSPRSKR CCCCCCCCCCCCHHC | 35.80 | 17081983 | |
91 | Phosphorylation | ASGRRSKSPRSKRNR CCCCCCCCCCHHCCC | 27.13 | 17081983 | |
99 | Phosphorylation | PRSKRNRSPHHSTVK CCHHCCCCCCCCCCC | 31.94 | 22167270 | |
103 | Phosphorylation | RNRSPHHSTVKVKQE CCCCCCCCCCCCCHH | 31.68 | 20068231 | |
104 | Phosphorylation | NRSPHHSTVKVKQER CCCCCCCCCCCCHHH | 21.71 | 20068231 | |
108 | Sumoylation | HHSTVKVKQEREDHP CCCCCCCCHHHCCCC | 40.50 | 28112733 | |
108 | Sumoylation | HHSTVKVKQEREDHP CCCCCCCCHHHCCCC | 40.50 | - | |
128 | Phosphorylation | DRQHREPSEQEHRRA HHCCCCCCHHHHHHH | 47.35 | 21955146 | |
147 | Phosphorylation | RDRHRGHSHQRRTSN HHHHHCCCCCCCCCC | 24.92 | 26329039 | |
152 | Phosphorylation | GHSHQRRTSNERPGS CCCCCCCCCCCCCCC | 37.79 | 22167270 | |
153 | Phosphorylation | HSHQRRTSNERPGSG CCCCCCCCCCCCCCC | 34.58 | 22167270 | |
159 | Phosphorylation | TSNERPGSGQGQGRD CCCCCCCCCCCCCCC | 30.53 | 21955146 | |
169 | Phosphorylation | GQGRDRDTQNLQAQE CCCCCCHHHHHHHHH | 21.91 | 17525332 | |
200 | Phosphorylation | NDVGGGGSESQELVP CCCCCCCCCCCCCCC | 37.03 | 23401153 | |
202 | Phosphorylation | VGGGGSESQELVPRP CCCCCCCCCCCCCCC | 30.56 | 17525332 | |
223 | Acetylation | KEVPAKEKPSFELSG CCCCCCCCCCEEECC | 45.30 | 25953088 | |
223 | Ubiquitination | KEVPAKEKPSFELSG CCCCCCCCCCEEECC | 45.30 | - | |
223 | Sumoylation | KEVPAKEKPSFELSG CCCCCCCCCCEEECC | 45.30 | 28112733 | |
225 | Phosphorylation | VPAKEKPSFELSGAL CCCCCCCCEEECCEE | 42.28 | 28450419 | |
229 | Phosphorylation | EKPSFELSGALLEDT CCCCEEECCEEEECC | 18.15 | 28450419 | |
236 | Phosphorylation | SGALLEDTNTFRGVV CCEEEECCCCEEEEE | 27.12 | 20068231 | |
238 | Phosphorylation | ALLEDTNTFRGVVIK EEEECCCCEEEEEEE | 19.46 | 29759185 | |
246 | Phosphorylation | FRGVVIKYSEPPEAR EEEEEEECCCCCCCC | 13.72 | 29759185 | |
247 | Phosphorylation | RGVVIKYSEPPEARI EEEEEECCCCCCCCC | 38.33 | 29759185 | |
301 | Ubiquitination | IDHPSCSKQHAVFQY CCCCCHHCCCEEEEE | 50.89 | - | |
301 | Acetylation | IDHPSCSKQHAVFQY CCCCCHHCCCEEEEE | 50.89 | 25953088 | |
308 | Phosphorylation | KQHAVFQYRLVEYTR CCCEEEEEEEEEEEC | 8.41 | - | |
313 | Phosphorylation | FQYRLVEYTRADGTV EEEEEEEEECCCCCC | 8.27 | - | |
314 | Phosphorylation | QYRLVEYTRADGTVG EEEEEEEECCCCCCC | 13.08 | - | |
325 | Acetylation | GTVGRRVKPYIIDLG CCCCCEECCEEEEEC | 30.23 | 26051181 | |
325 | Ubiquitination | GTVGRRVKPYIIDLG CCCCCEECCEEEEEC | 30.23 | - | |
342 | Ubiquitination | NGTFLNNKRIEPQRY CCCCCCCCCCCCCEE | 54.39 | - | |
349 | Phosphorylation | KRIEPQRYYELKEKD CCCCCCEEEECCHHC | 8.95 | 27251275 | |
350 | Phosphorylation | RIEPQRYYELKEKDV CCCCCEEEECCHHCC | 19.58 | 27251275 | |
353 | Ubiquitination | PQRYYELKEKDVLKF CCEEEECCHHCCEEE | 51.26 | - | |
367 | Phosphorylation | FGFSSREYVLLHESS ECCCCCCEEEEECCC | 8.69 | 20873877 | |
373 | Phosphorylation | EYVLLHESSDTSEID CEEEEECCCCCCCCC | 23.83 | 30108239 | |
374 | Phosphorylation | YVLLHESSDTSEIDR EEEEECCCCCCCCCC | 41.75 | 30108239 | |
376 | Phosphorylation | LLHESSDTSEIDRKD EEECCCCCCCCCCCC | 30.15 | 30108239 | |
377 | Phosphorylation | LHESSDTSEIDRKDD EECCCCCCCCCCCCC | 37.23 | 30108239 | |
394 | Phosphorylation | EEEEEEVSDS----- HHHHHHHCCC----- | 35.10 | 30266825 | |
396 | Phosphorylation | EEEEVSDS------- HHHHHCCC------- | 34.32 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNIP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNIP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNIP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614501 | Psychomotor retardation, epilepsy, and craniofacial dysmorphism (PMRED) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52 AND SER-54, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-49; SER-52 ANDSER-54, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-169 AND SER-202, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-89; SER-91 ANDSER-153, AND MASS SPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"PDSM, a motif for phosphorylation-dependent SUMO modification."; Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J.,Nakai A., Sistonen L.; Proc. Natl. Acad. Sci. U.S.A. 103:45-50(2006). Cited for: SUMOYLATION AT LYS-30, AND MUTAGENESIS OF LYS-30. |